BVF Inc’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

BVF Inc’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-131,250	Closed	-$315K	–	63
2024 Q2	$315K	Hold	131,250	–	–	0.01%	60
2024 Q1	$646K	Hold	131,250	–	–	0.02%	60
2023 Q4	$548K	Hold	131,250	–	–	0.01%	69
2023 Q3	$1.94M	Hold	131,250	–	–	0.05%	64
2023 Q2	$3.83M	Buy	+131,250	New	+$4.06M	0.11%	56

Other funds holding ASLN

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

BVF Inc's ASLN Position: Q3 2024 in Review

BVF Inc sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2024, closing a stake of 131,250 shares — an estimated $315K sold.

BVF Inc first reported a position in ASLN in Q2 2023 and held it in 5 quarters. The position peaked at $3.83M in Q2 2023. 1 fund tracked by Wall St. Rank holds ASLN as of Q3 2024.

BVF Inc reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2024 after selling out during the quarter.
BVF Inc sold 131,250 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2024, an estimated $315K.
BVF Inc first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q2 2023 and held it in 5 quarters.
BVF Inc's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $3.83M in Q2 2023.
1 fund tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2024.

Based on BVF Inc's 13F filing for Q3 2024, filed 14 Nov 2024.